DE602004019134D1 - Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten - Google Patents

Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten

Info

Publication number
DE602004019134D1
DE602004019134D1 DE602004019134T DE602004019134T DE602004019134D1 DE 602004019134 D1 DE602004019134 D1 DE 602004019134D1 DE 602004019134 T DE602004019134 T DE 602004019134T DE 602004019134 T DE602004019134 T DE 602004019134T DE 602004019134 D1 DE602004019134 D1 DE 602004019134D1
Authority
DE
Germany
Prior art keywords
hgf
growth factor
various forms
body fluids
fast determination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004019134T
Other languages
English (en)
Inventor
Fariba Nayeri
Tayeb Nayeri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peas Institut AB
Original Assignee
Peas Institut AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peas Institut AB filed Critical Peas Institut AB
Publication of DE602004019134D1 publication Critical patent/DE602004019134D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE602004019134T 2003-09-29 2004-09-29 Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten Active DE602004019134D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50719203P 2003-09-29 2003-09-29
PCT/IB2004/003606 WO2005031365A2 (en) 2003-09-29 2004-09-29 Rapid determination of hepatocyte growth factor (hgf) in the body fluids

Publications (1)

Publication Number Publication Date
DE602004019134D1 true DE602004019134D1 (de) 2009-03-05

Family

ID=34393223

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004019134T Active DE602004019134D1 (de) 2003-09-29 2004-09-29 Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten

Country Status (7)

Country Link
US (1) US20070224703A1 (de)
EP (1) EP1687636B1 (de)
AT (1) ATE421093T1 (de)
DE (1) DE602004019134D1 (de)
DK (1) DK1687636T3 (de)
ES (1) ES2321105T3 (de)
WO (1) WO2005031365A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1957102B1 (de) * 2005-11-16 2012-01-18 Fariba Nayeri Verfahren zur hemmung von krebsbildung und/oder metastasen bei einer person durch endogene c-met-liganden und -hemmer
CN102264230B (zh) 2008-11-10 2014-12-10 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
EP2446274B1 (de) 2009-06-26 2017-08-09 PEAS Institut AB Verfahren zur bestimmung biologisch aktiver hgf
US8865164B2 (en) 2010-11-02 2014-10-21 Kypha, Inc. Detecting complement activation
CA2816423A1 (en) 2010-11-02 2012-05-31 Kypha, Inc. Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders
JP6119607B2 (ja) * 2011-09-20 2017-04-26 コニカミノルタ株式会社 検体希釈用液、それを用いたキットおよび蛍光測定方法
SE536400C2 (sv) 2012-02-22 2013-10-08 Peas Inst Ab Ny metod för snabb detektion av hepatocyttillväxtfaktor i biologiska vätskor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1321488C (en) * 1987-08-22 1993-08-24 Martin Francis Finlan Biological sensors
US5648273A (en) * 1989-12-27 1997-07-15 The United States Of America, As Represented By The Department Of Health And Human Services Hepatic growth factor receptor is the MET proto-oncogene
US5656443A (en) * 1994-07-29 1997-08-12 Long Island Jewish Medical Center Method of diagnosing bladder cancer
US6265551B1 (en) * 1995-06-01 2001-07-24 Dana-Farber Cancer Institute, Inc. Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof
AU7157896A (en) * 1995-09-12 1997-04-01 Children's Hospital Medical Center Of Northern California Cystic fibrosis therapy
US5827673A (en) * 1996-08-13 1998-10-27 Akira Matsumori Method of detecting myocardial infarction
WO2001044294A2 (en) * 1999-12-15 2001-06-21 Entremed, Inc. Compositions and methods for inhibiting endothelial cell proliferation
ES2295198T3 (es) * 2000-08-28 2008-04-16 Damavand Wound Ab Los efectos sinergicos de hgf y tratamiento antibacteriano.
US20020115224A1 (en) * 2001-02-16 2002-08-22 Ulrich Rudel Method for the preparation of optical (bio)chemical sensor devices
US6730487B2 (en) * 2001-04-03 2004-05-04 Trustees Of Columbia University In The City Of New York Surface plasmon resonance biosensor for measurement of anti-glycolipid antibody levels in neuropathy

Also Published As

Publication number Publication date
EP1687636A2 (de) 2006-08-09
DK1687636T3 (da) 2009-05-11
US20070224703A1 (en) 2007-09-27
ES2321105T3 (es) 2009-06-02
ATE421093T1 (de) 2009-01-15
WO2005031365A3 (en) 2005-07-07
EP1687636B1 (de) 2009-01-14
WO2005031365A2 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
ATE410687T1 (de) Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test
DE69917051D1 (de) "flow-zytometrischer" vollblut- dendritzelle- immunfunctiontest
ATE241139T1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
TW200613729A (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
ATE499607T1 (de) Analytentestsystem unter verwendung nichtenzymatischer analytenerkennungselemente
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
ATE485514T1 (de) Immunoassay mit mehreren analyten
RU2011125320A (ru) Способы, устройства и наборы для детекции или мониторинга острого повреждения почек
ATE514092T1 (de) Vorrichtung und verfahren zur simultanen bestimmung von blutgruppenantigenen
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
DE602004019134D1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
ATE360213T1 (de) Bestimung und quantifizierung von erythrocytenpopulationen in proben
ATE478337T1 (de) Methoden zum nachweis analyten in proben
ATE369564T1 (de) Differenzielles immunoassay für myoglobin
DE602004015953D1 (de) Festphase immunochromatographische testverfahren
ATE495267T1 (de) Diagnostisches verfahren zum nachweis von helicobacter pylori
WO2002077645A3 (en) Method for the measurement of soluble analytes
ATE473443T1 (de) Abstufung von immunantworten
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
ATE466884T1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest
DE69928125D1 (de) EIN VERFAHREN ZUM AUFFINDEN UND/ODER QUANTIFIZIEREN EINES SPEZIFISCHEN IgE-ANTIKÖRPERS IN EINER FLÜSSIGEN PROBE
ATE426171T1 (de) VERFAHREN UND REAGENZ ZUR PRUFUNG VON MEHRORGANSTÍRUNG IN ßSYSTEMIC INFLAMMATORY RESPONSE SYNDROMEß (SIRS) DURCH MESSUNG VON CYTOCHROM C
ATE520985T1 (de) Verfahren zur bestimmung von antigen und antikörper gegen das antigen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition